aTyr Pharma (ATYR)

• Market cap: $45.6M
• 1 day: 5.68%
• 5 days: 2.29%
• 1 month: -7.66%
• 3 months: -47.97%
• 6 months: -36.54%
• Year to date: -38.69%
• 1 year: -91.51%
• 5 years: -90.22%
• 10 years: -98.9%
• Sector: Healthcare
• Industry: Biotechnology

About: aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Employees: 58